Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer

The molecular mechanism underlying the resistance of AKT inhibitors in breast cancer is still elusive. Here, the authors demonstrate that BRD4/FOXO3a axis upregulates CDK6 promoter activity to promote resistance to AKT inhibition in breast cancer cells and that blocking the action of CDK6 re-sensiti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jingyi Liu, Zhibing Duan, Weijie Guo, Lei Zeng, Yadi Wu, Yule Chen, Fang Tai, Yifan Wang, Yiwei Lin, Qiang Zhang, Yanling He, Jiong Deng, Rachel L. Stewart, Chi Wang, Pengnian Charles Lin, Saghi Ghaffari, B. Mark Evers, Suling Liu, Ming-Ming Zhou, Binhua P. Zhou, Jian Shi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/47361ecca973405cbbf1642486398298
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:47361ecca973405cbbf1642486398298
record_format dspace
spelling oai:doaj.org-article:47361ecca973405cbbf16424863982982021-12-02T15:33:45ZTargeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer10.1038/s41467-018-07258-y2041-1723https://doaj.org/article/47361ecca973405cbbf16424863982982018-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-07258-yhttps://doaj.org/toc/2041-1723The molecular mechanism underlying the resistance of AKT inhibitors in breast cancer is still elusive. Here, the authors demonstrate that BRD4/FOXO3a axis upregulates CDK6 promoter activity to promote resistance to AKT inhibition in breast cancer cells and that blocking the action of CDK6 re-sensitizes resistant cancer cells to growth inhibition.Jingyi LiuZhibing DuanWeijie GuoLei ZengYadi WuYule ChenFang TaiYifan WangYiwei LinQiang ZhangYanling HeJiong DengRachel L. StewartChi WangPengnian Charles LinSaghi GhaffariB. Mark EversSuling LiuMing-Ming ZhouBinhua P. ZhouJian ShiNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-17 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Jingyi Liu
Zhibing Duan
Weijie Guo
Lei Zeng
Yadi Wu
Yule Chen
Fang Tai
Yifan Wang
Yiwei Lin
Qiang Zhang
Yanling He
Jiong Deng
Rachel L. Stewart
Chi Wang
Pengnian Charles Lin
Saghi Ghaffari
B. Mark Evers
Suling Liu
Ming-Ming Zhou
Binhua P. Zhou
Jian Shi
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
description The molecular mechanism underlying the resistance of AKT inhibitors in breast cancer is still elusive. Here, the authors demonstrate that BRD4/FOXO3a axis upregulates CDK6 promoter activity to promote resistance to AKT inhibition in breast cancer cells and that blocking the action of CDK6 re-sensitizes resistant cancer cells to growth inhibition.
format article
author Jingyi Liu
Zhibing Duan
Weijie Guo
Lei Zeng
Yadi Wu
Yule Chen
Fang Tai
Yifan Wang
Yiwei Lin
Qiang Zhang
Yanling He
Jiong Deng
Rachel L. Stewart
Chi Wang
Pengnian Charles Lin
Saghi Ghaffari
B. Mark Evers
Suling Liu
Ming-Ming Zhou
Binhua P. Zhou
Jian Shi
author_facet Jingyi Liu
Zhibing Duan
Weijie Guo
Lei Zeng
Yadi Wu
Yule Chen
Fang Tai
Yifan Wang
Yiwei Lin
Qiang Zhang
Yanling He
Jiong Deng
Rachel L. Stewart
Chi Wang
Pengnian Charles Lin
Saghi Ghaffari
B. Mark Evers
Suling Liu
Ming-Ming Zhou
Binhua P. Zhou
Jian Shi
author_sort Jingyi Liu
title Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
title_short Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
title_full Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
title_fullStr Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
title_full_unstemmed Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
title_sort targeting the brd4/foxo3a/cdk6 axis sensitizes akt inhibition in luminal breast cancer
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/47361ecca973405cbbf1642486398298
work_keys_str_mv AT jingyiliu targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT zhibingduan targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT weijieguo targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT leizeng targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT yadiwu targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT yulechen targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT fangtai targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT yifanwang targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT yiweilin targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT qiangzhang targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT yanlinghe targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT jiongdeng targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT rachellstewart targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT chiwang targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT pengniancharleslin targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT saghighaffari targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT bmarkevers targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT sulingliu targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT mingmingzhou targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT binhuapzhou targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
AT jianshi targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer
_version_ 1718387020989988864